Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both low-level light therapy and 5% minoxidil are effective and safe for treating male hair loss, with no significant difference in results.

Thyroid receptor β can help develop new drugs to treat hair loss.

A gene mutation in Lama3 is linked to a common type of hair loss.

Men with hair loss often have abnormal cholesterol levels, so early screening is advised.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Scalp threading with PDO threads is an effective treatment for male crown baldness.

Botulinum toxin injections improved hair thinning in a woman with hair loss.

Females with androgenic alopecia have significantly lower vitamin D3 and ferritin levels.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Early hair loss may predict heart disease.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

Early-onset male hair loss may be linked to higher cardiovascular risk.

The 5 mg dose of oral minoxidil is not more effective than the 2.5 mg dose for treating male hair loss.

Social media doesn't significantly influence treatment choices for hair loss, but better education on options is needed.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Oral minoxidil is as effective as topical minoxidil for male hair loss but has more side effects like excessive hair growth and headaches.

Adipose-derived stem cells may help with hair loss, but more research is needed.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Young males with severe early-onset hair loss may have a higher risk of metabolic syndrome.

ECM changes may play a role in hair loss, with differences between males and females.

Higher homocysteine levels may inhibit hair growth and are linked to androgenetic alopecia.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.